Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Imperial Brands PLC | 13 |
| 2 | Nestle SA | 10 |
| 3 | Massachusetts Institute of Technology | 2 |
| 4 | Bpifrance SA | 1 |
| 5 | Cedars-Sinai Health System | 1 |
| 6 | Fresenius SE and Co KGaA | 1 |
| 7 | State University System of Florida | 1 |
| 8 | University of California | 1 |
| 9 | University of Pittsburgh | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 36 |
| 2 | A61P | Therapeutic activity (drug indications) | 32 |
| 3 | C07H | Sugars and derivatives | 20 |
| 4 | C07D | Heterocyclic compounds | 18 |
| 5 | A24F | 16 |
| 6 | A61M | Devices for introducing media into the body | 16 |
| 7 | Y02A | Climate change adaptation | 16 |
| 8 | C07C | Acyclic and carbocyclic compounds | 11 |
| 9 | A24B | 10 | |
| 10 | A01N | Preservation of bodies; biocides; pest repellents | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| METHODS AND DEVICES FOR COMPOUND DELIVERY | 2014 | Imperial Brands PLC | 83 |
| METHODS AND DEVICES FOR SMOKING URGE RELIEF | 2015 | Imperial Brands PLC | 56 |
| Methods and devices for smoking urge relief | 2017 | Imperial Brands PLC | 19 |
| Apparatus for aerosol production for the production of an aerosol condensate | 2014 | Imperial Brands PLC | 19 |
| METHODS AND DEVICES FOR COMPOUND DELIVERY | 2015 | Imperial Brands PLC | 15 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | L. Mester | Institut de Chimie des Substances Naturelles | 8 |
| 2 | Mester de Parajd L | 6 | |
| 3 | Mester de Parajd M | 6 | |
| 4 | N. H. Antia | Foundation for Medical Research | 4 |
| 5 | M. Mester | Institut de Chimie des Substances Naturelles | 3 |
| 6 | S Balakrishnan | 3 | |
| 7 | László Szabados | Institut de Chimie des Substances Naturelles | 3 |
| 8 | G Baquillon | 3 | |
| 9 | P. R. Mahadevan | Foundation for Medical Research | 3 |
| 10 | E. J. AMBROSE | Institut de Chimie des Substances Naturelles | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Inhibition of the incorporation of [3H]DOPA in Mycobacterium leprae by desoxyfructo-serotonin | 1980 | 8 | Leprosy Research and Treatment |
| Maillard type carbonyl-amine reactions in vivo and their physiological effects. | 1981 | 5 | Advanced Glycation End Products research |
| EFFECT OF DEOXYFRUCTOSEROTONIN (DFS) ON LEPROMATOUS LEPROSY | 1988 | 5 | Leprosy Research and Treatment |
| Deoxyfructo-serotonin: a new drug with anti-leprosy activity. | 1983 | 4 | Cancer Treatment and Pharmacology |
| The action of deoxyfructose serotonin on intracellular bacilli and on host response in leprosy | 1985 | 4 | Diet, Metabolism, and Disease |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Deoxyfructo-serotonin?
Which organizations hold the most patents for this compound?
What has been the recent trend in patent filings for Deoxyfructo-serotonin?
What are the primary research topics associated with this compound?
Who are the leading authors publishing on this compound?